Paclitaxel + carboplatin, docetaxel alone, for endometrial cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1579, 2007-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paclitaxel and docetaxel in the treatment of breast cancer

By Saloustros Emmanouel Mavroudis Dimitris Georgoulias Vassilis

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2603-2616

Informa Healthcare

Access to resources Recommend Favorite

Carboplatin/docetaxel/paclitaxel: Peripheral nerve disorders: case report

Reactions Weekly, Vol. 1, Iss. 1150, 2007-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Carboplatin/docetaxel/paclitaxel: Immediate hypersensitivity: 11 case reports

Reactions Weekly, Vol. 1, Iss. 1355, 2011-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite

Carboplatin/docetaxel/paclitaxel: Abdominopelvic abscess, bronchospasm and neuropathy: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1432, 2012-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Docetaxel/carboplatin combo delivers in ovarian cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 631, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite